C.F.R. homeSearch C.F.R.
C.F.R.Title 21Chapter I—Food and Drug Administration, Department of Health and Human ServicesSubchapter H—Medical DevicesPart 812—Investigational Device ExemptionsSubpart A—General Provisions

21 C.F.R. § 812.5 (2026)

Labeling of investigational devices

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 cited 1995–2022 8citing cases
At a glance

Courts have cited this section in 8 opinions since 1995, 1 of them in the last five years.

(a) Contents. An investigational device or its immediate package shall bear a label with the following information: the name and place of business of the manufacturer, packer, or distributor (in accordance with § 801.1), the quantity of contents, if appropriate, and the following statement: “CAUTION—Investigational device. Limited by Federal (or United States) law to investigational use.” The label or other labeling shall describe all relevant contraindications, hazards, adverse effects, interfering substances or devices, warnings, and precautions.

(b) Prohibitions. The labeling of an investigational device shall not bear any statement that is false or misleading in any particular and shall not represent that the device is safe or effective for the purposes for which it is being investigated.

(c) Animal research. An investigational device shipped solely for research on or with laboratory animals shall bear on its label the following statement: “CAUTION—Device for investigational use in laboratory animals or other tests that do not involve human subjects.”

(d) The appropriate FDA Center Director, according to the procedures set forth in § 801.128 or § 809.11 of this chapter, may grant an exception or alternative to the provisions in paragraphs (a) and (c) of this section, to the extent that these provisions are not explicitly required by statute, for specified lots, batches, or other units of a device that are or will be included in the Strategic National Stockpile.

[45 FR 3751, Jan. 18, 1980, as amended at 45 FR 58842, Sept. 5, 1980; 72 FR 73602, Dec. 28, 2007]
The 8 cases that cite 21 C.F.R. § 812.5 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENAda M. Martin v. Telectronics Pacing Sys., Inc., 105 F.3d 1090 (6th Cir. 1997).
cites § 812.5 2×cited by 52 cases
Where it cites § 812.5
“” 21 C.F.R. § 812.5 (a). In addition, during the application process, the manufacturer must submit the label to the FDA for its review.”
The case’s holding
State products liability claims are preempted when specific federal regulations apply to the device in question, such as those governing an investigational device exemption.
Later courts cite it for
“federal requirement 'must be applicable to the device in question... and specific to a particular device.” · 3 citing courts
2
GREENFemrite v. Abbott Nw. Hosp., 568 N.W.2d 535 (Minn. Ct. App. 1997).
cites § 812.5 2×cited by 17 cases
Where it cites § 812.5
“, 21 C.F.R. § 812.5 (1996) (requiring investigational device to be labeled as such); 21 C.”
Later courts cite it for
“belongs to the class of persons that the regulation is intended to protect,” · 3 citing courts
3
GREENConnelly v. Iolab Corp., 927 S.W.2d 848 (Mo. 1996).
cites § 812.5 1×cited by 27 cases
Where it cites § 812.5
“For example, 21 C.F.R. § 812.5 governs the contents of investigational device labels, and § 812.”
Later courts cite it for
“nothing in the fda regulations prohibits iolab from adding a warning to the label regarding unreasonably high complication rates.” · 2 citing courts
4
GREENBourquin v. Melsungen, 670 A.2d 1322 (Conn. App. Ct. 1996).
cites § 812.5 1×cited by 27 cases
Where it cites § 812.5
“’ ”21 C.F.R. § 812.5 (a) (1995). Before any IDE may be used on a patient, an informed consent must be obtained.”
The case’s holding
Res ipsa loquitur applies when a caregiver administers the wrong medication or disputed anesthetic, so expert testimony is not required where the failure is within common knowledge.
Later courts cite it for
“laboratory sample - for testing only” · 1 citing court
5
GREENGuckin v. Nagle, 259 F. Supp. 2d 406 (E.D. Pa. 2003).
cites § 812.5 1×cited by 8 cases
Where it cites § 812.5
“20 (b)(3), whether the product labeling is complete, 21 C.F.R. § 812.5 , and whether the consent materials comply with the provisions of 21 C.”
cites § 812.5 1×cited by 11 cases
Vacated: 2 citing opinions add another limit ("vacated (caution)").
Where it cites § 812.5
“7 prevents the commercialization and promotion of in-vestigational devices, and prohibits any representation that “an investigational device is safe or effective for the purposes for which it is being investigated”; and § 812.”
Later courts cite it for
“the representations that can, cannot, and must be made about an investigational device are all determined by the fda.” · 2 citing courts
7
NO FLAGReinoehl v. Centers for Disease Control & Prevention, No. 3:21-cv-00608 (N.D. Ind. Feb. 16, 2022).
cites § 812.5 1×cited by 0 casesunknown
Where it cites § 812.5
“166, and 21 CFR § 812.5 .” Alongside the CDC and Dr.”
8
NO FLAGRobinson v. Endovascular Tech., Inc., 190 Cal. App. 4th 1490 (Ct. App. 2010).
cites § 812.5 1×cited by 0 cases
Where it cites § 812.5
“In addition to listing the relevant contraindications, hazards, adverse effects, warnings and precautions that must be included on the labeling, the FDA also requires that the labeling “shall not bear any statement that is false or misleading in any particular and shall not…”

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
199520082022

One bar per year. Tallest: 2 cases in 1996. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
6th Cir.2Cal. Ct. App.1Conn. App. Ct.1N.D. Ind.1Minn. Ct. App.1Mo.1E.D. Pa.1
By subsection

Courts have not cited this section by subsection, so its cases are not split up here. The Leading cases tab lists the cases that cite it most heavily.

Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com